EcoDrugPlus

Coagulation Factor Vii, Like

Ensembl ID : ENSATEG00000008960
Gene Symbol: F7L
3 Cross references
203 Possible Orthologues:

Coiled-Coil Domain Containing 6

Ensembl ID : ENSATEG00000008540
Gene Symbol: CCDC6
3 Cross references
208 Possible Orthologues:

Colony Stimulating Factor 1 Receptor, A

Ensembl ID : ENSATEG00000008474
Gene Symbol: CSF1RA
3 Cross references
207 Possible Orthologues:

Colony Stimulating Factor 1 Receptor, B

Ensembl ID : ENSATEG00000014142
Gene Symbol: CSF1RB
2 Cross references
199 Possible Orthologues:

Complement C1s Subcomponent-Like

Ensembl ID : ENSATEG00000021386
Gene Symbol: LOC113169271
2 Cross references
176 Possible Orthologues:

Complement Component 1, S Subcomponent .2

Ensembl ID : ENSATEG00000021318
Gene Symbol: C1S.2
1 Cross references
161 Possible Orthologues:

Corticotropin-Releasing Factor Receptor 1-Like

Ensembl ID : ENSATEG00000009552
Gene Symbol: LOC113156828
2 Cross references
208 Possible Orthologues:

Cyclin D1

Ensembl ID : ENSATEG00000009890
Gene Symbol: CCND1
2 Cross references
232 Possible Orthologues:

Cyclin Dependent Kinase 4

Ensembl ID : ENSATEG00000027584
Gene Symbol: CDK4
3 Cross references
239 Possible Orthologues:

Cyclin-Dependent Kinase 1

Ensembl ID : ENSATEG00000006538
Gene Symbol: CDK1
2 Cross references
246 Possible Orthologues:

Cyclin-Dependent Kinase 2

Ensembl ID : ENSATEG00000024533
Gene Symbol: CDK2
2 Cross references
203 Possible Orthologues:

Cyclin-Dependent Kinase 5

Ensembl ID : ENSATEG00000005993
Gene Symbol: CDK5
3 Cross references
169 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).